300381 溢多利
已收盘 04-24 15:00:00
资讯
新帖
简况
溢多利(300381)3月31日股东户数2.02万户，较上期减少1%
证券之星 · 17:12
溢多利(300381)3月31日股东户数2.02万户，较上期减少1%
图解溢多利年报：第四季度单季净利润同比下降224.46%
证券之星 · 01:19
图解溢多利年报：第四季度单季净利润同比下降224.46%
溢多利（300381）披露注销回购股份并减少注册资本公告，4月20日股价下跌0.16%
证券之星 · 04-20
溢多利（300381）披露注销回购股份并减少注册资本公告，4月20日股价下跌0.16%
溢多利(300381)3月31日股东户数2.02万户，较上期减少1%
证券之星 · 04-07
溢多利(300381)3月31日股东户数2.02万户，较上期减少1%
股市必读：溢多利（300381）4月1日董秘有最新回复
证券之星 · 04-02
股市必读：溢多利（300381）4月1日董秘有最新回复
溢多利公布国际专利申请：“碱性蛋白酶突变体及其应用”
证券之星 · 03-07
溢多利公布国际专利申请：“碱性蛋白酶突变体及其应用”
溢多利（300381）披露向2025年限制性股票激励计划激励对象授予预留限制性股票的公告，3月6日股价上涨3.76%
证券之星 · 03-06
溢多利（300381）披露向2025年限制性股票激励计划激励对象授予预留限制性股票的公告，3月6日股价上涨3.76%
溢多利（300381）披露产品获得欧盟批准注册公告，3月2日股价下跌4.13%
证券之星 · 03-02
溢多利（300381）披露产品获得欧盟批准注册公告，3月2日股价下跌4.13%
溢多利：截至2026年2月27日，公司股东人数为20415户
证券之星 · 03-02
溢多利：截至2026年2月27日，公司股东人数为20415户
溢多利最新公告：公司产品获得欧盟批准注册
证券之星 · 03-01
溢多利最新公告：公司产品获得欧盟批准注册
溢多利：公司立足生物产业，致力于生物技术在营养与健康、食品饮料、护理清洁、纺织皮革、纸浆造纸、生物能源、生态农业、再生资源等领域的绿色、安全、高效应用
证券之星 · 02-10
溢多利：公司立足生物产业，致力于生物技术在营养与健康、食品饮料、护理清洁、纺织皮革、纸浆造纸、生物能源、生态农业、再生资源等领域的绿色、安全、高效应用
股市必读：溢多利(300381)股东户数2.01万户，较上期增加1.11%
证券之星 · 02-03
股市必读：溢多利(300381)股东户数2.01万户，较上期增加1.11%
溢多利最新公告：2025年预亏1300万元—2600万元同比由盈转亏
证券之星 · 01-28
溢多利最新公告：2025年预亏1300万元—2600万元同比由盈转亏
溢多利：公司R-PET酶目前已完成菌株构建及小试中试
证券之星 · 01-23
溢多利：公司R-PET酶目前已完成菌株构建及小试中试
溢多利：洗涤酶产品研发和验证周期相对较长
证券之星 · 01-14
溢多利：洗涤酶产品研发和验证周期相对较长
溢多利（300381）披露控股股东部分股份质押展期公告，1月6日股价上涨1.49%
证券之星 · 01-06
溢多利（300381）披露控股股东部分股份质押展期公告，1月6日股价上涨1.49%
溢多利：截至2025年12月31日股东人数为19833户
证券之星 · 01-06
溢多利：截至2025年12月31日股东人数为19833户
溢多利：前三季度为加快海外市场拓展，销售费用略有增长
证券日报 · 2025-12-24
溢多利：前三季度为加快海外市场拓展，销售费用略有增长
溢多利：公司现有的电镀过氧化氢酶主要用于电子产品生产过程中的清洗环节
证券日报 · 2025-12-24
溢多利：公司现有的电镀过氧化氢酶主要用于电子产品生产过程中的清洗环节
溢多利(300381)12月19日股东户数2.03万户，较上期增加0.05%
证券之星 · 2025-12-23
溢多利(300381)12月19日股东户数2.03万户，较上期增加0.05%
加载更多
公司概况
公司名称：
广东溢多利生物科技股份有限公司
所属行业：
医药制造业
上市日期：
2014-01-28
主营业务：
广东溢多利生物科技股份有限公司的主营业务是生物酶制剂、生物合成品及植物提取物的研发、生产、销售和服务，并向客户提供整体生物技术解决方案。公司的主要产品是生物酶制剂、生物合成品、植物提取物。公司荣获了国家工信部认定的“饲料用酶制剂产品国家制造业单项冠军企业”荣誉称号。
发行价格：
27.88
{"stockData":{"symbol":"300381","market":"SZ","secType":"STK","nameCN":"溢多利","latestPrice":6.19,"timestamp":1777014222000,"preClose":6.11,"halted":0,"volume":7050894,"delay":0,"changeRate":0.0131,"floatShares":488999999,"shares":491000000,"eps":0.0133,"marketStatus":"已收盘","change":0.08,"latestTime":"04-24 15:00:00","open":6.1,"high":6.23,"low":6.05,"amount":43286200,"amplitude":0.0295,"askPrice":6.2,"askSize":324,"bidPrice":6.19,"bidSize":126,"shortable":0,"etf":0,"ttmEps":0.0133,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1777253400000},"marketStatusCode":5,"adr":0,"adjPreClose":6.11,"symbolType":"stock","openAndCloseTimeList":[[1776994200000,1777001400000],[1777006800000,1777014000000]],"highLimit":6.72,"lowLimit":5.5,"ibTradeSell":false,"ibTradeBuySell":false,"totalEquity":491061461,"isCdr":false,"pbRate":1.16,"roa":"--","peRate":465.413534,"roe":"0.69%","epsLYR":0.0634,"committee":-0.824912,"marketValue":3040000000,"turnoverRate":0.0144,"status":0,"floatMarketCap":3029000000},"requestUrl":"/m/hq/s/300381","defaultTab":"news","newsList":[{"id":"2630870599","title":"溢多利(300381)3月31日股东户数2.02万户，较上期减少1%","url":"https://stock-news.laohu8.com/highlight/detail?id=2630870599","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2630870599?lang=zh_cn&edition=full","pubTime":"2026-04-25 17:12","pubTimestamp":1777108336,"startTime":"0","endTime":"0","summary":"证券之星消息，近日溢多利披露，截至2026年3月31日公司股东户数为2.02万户，较2月27日减少205.0户，减幅为1.0%。在化学制药行业个股中，溢多利股东户数低于行业平均水平，截至3月31日，化学制药行业平均股东户数为3.52万户。从股价来看，2026年2月27日至2026年3月31日，溢多利区间跌幅为6.83%，在此期间股东户数减少205.0户，减幅为1.0%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026042500032667.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","300381","BK0077","BK0070"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2630182920","title":"图解溢多利年报：第四季度单季净利润同比下降224.46%","url":"https://stock-news.laohu8.com/highlight/detail?id=2630182920","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2630182920?lang=zh_cn&edition=full","pubTime":"2026-04-25 01:19","pubTimestamp":1777051163,"startTime":"0","endTime":"0","summary":"证券之星消息，溢多利2025年年报显示，当年度公司主营收入8.32亿元，同比上升0.73%；归母净利润-1977.95万元，同比下降163.62%；扣非净利润-1803.89万元，同比下降401.44%；其中2025年第四季度，公司单季度主营收入2.19亿元，同比上升0.64%；单季度归母净利润-3798.39万元，同比下降224.46%；单季度扣非净利润-3680.62万元，同比下降356.79%；负债率11.34%，投资收益176.02万元，财务费用-540.51万元，毛利率45.42%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026042500003921.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300381"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2628172182","title":"溢多利（300381）披露注销回购股份并减少注册资本公告，4月20日股价下跌0.16%","url":"https://stock-news.laohu8.com/highlight/detail?id=2628172182","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2628172182?lang=zh_cn&edition=full","pubTime":"2026-04-20 22:28","pubTimestamp":1776695291,"startTime":"0","endTime":"0","summary":"近日，广东溢多利生物科技股份有限公司披露《关于注销回购股份并减少注册资本暨通知债权人的公告》。公告显示，公司于2026年4月3日召开第八届董事会第十七次会议，于2026年4月20日召开2026年第一次临时股东会，审议通过《关于变更回购股份用途并注销的议案》《关于减少注册资本及修订<公司章程>部分条款的议案》，同意注销公司回购专用证券账户中的10,887,600股股票，注册资本由491,061,461元减少至480,173,861元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026042000037317.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","300381","BK0077","BK0070"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2625936663","title":"溢多利(300381)3月31日股东户数2.02万户，较上期减少1%","url":"https://stock-news.laohu8.com/highlight/detail?id=2625936663","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2625936663?lang=zh_cn&edition=full","pubTime":"2026-04-07 17:12","pubTimestamp":1775553141,"startTime":"0","endTime":"0","summary":"证券之星消息，近日溢多利披露，截至2026年3月31日公司股东户数为2.02万户，较2月27日减少205.0户，减幅为1.0%。在化学制药行业个股中，溢多利股东户数低于行业平均水平，截至3月31日，化学制药行业平均股东户数为3.47万户。从股价来看，2026年2月27日至2026年3月31日，溢多利区间跌幅为6.83%，在此期间股东户数减少205.0户，减幅为1.0%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026040700023996.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0070","300381","BK0077"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2624836543","title":"股市必读：溢多利（300381）4月1日董秘有最新回复","url":"https://stock-news.laohu8.com/highlight/detail?id=2624836543","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2624836543?lang=zh_cn&edition=full","pubTime":"2026-04-02 00:54","pubTimestamp":1775062452,"startTime":"0","endTime":"0","summary":"截至2026年4月1日收盘，溢多利报收于6.67元，上涨1.83%，换手率1.95%，成交量9.53万手，成交额6343.04万元。董秘最新回复投资者： 请问公司去年预亏，今年一季度公司主营及毛利率环比有哪些积极变化？塑料降解酶中试进展何如？董秘： 您好，具体情况详见公司届时在巨潮资讯网披露的《2025年年度报告》及《2026年第一季度报告》，感谢您的关注！交易信息汇总资金流向4月1日主力资金净流出78.67万元；游资资金净流出23.79万元；散户资金净流入102.45万元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026040200000651.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0077","300381","BK0070","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2617165368","title":"溢多利公布国际专利申请：“碱性蛋白酶突变体及其应用”","url":"https://stock-news.laohu8.com/highlight/detail?id=2617165368","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2617165368?lang=zh_cn&edition=full","pubTime":"2026-03-07 05:44","pubTimestamp":1772833468,"startTime":"0","endTime":"0","summary":"证券之星消息，根据企查查数据显示溢多利（300381）公布了一项国际专利申请，专利名为“碱性蛋白酶突变体及其应用”，专利申请号为PCT/CN2024/114740，国际公布日为2026年3月5日。专利详情如下：图片来源：世界知识产权组织（WIPO）今年以来溢多利已公布的国际专利申请1个。结合公司2025年中报财务数据，2025上半年公司在研发方面投入了4747.14万元，同比减2.48%。数据来源：企查查以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026030700002605.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300381","BK0070","BK0077","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2617636517","title":"溢多利（300381）披露向2025年限制性股票激励计划激励对象授予预留限制性股票的公告，3月6日股价上涨3.76%","url":"https://stock-news.laohu8.com/highlight/detail?id=2617636517","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2617636517?lang=zh_cn&edition=full","pubTime":"2026-03-06 22:36","pubTimestamp":1772807781,"startTime":"0","endTime":"0","summary":"近日，广东溢多利生物科技股份有限公司发布《关于向2025年限制性股票激励计划激励对象授予预留限制性股票的公告》。公告显示，公司于2026年3月6日召开董事会，确定向40名激励对象授予104万股第二类限制性股票，授予价格为3.63元/股，股票来源为二级市场回购及定向发行。本次授予的限制性股票归属期分别为自授予日起12个月、24个月、36个月后，归属比例为50%、50%。本次激励计划已履行相关审批程序，授予条件已满足。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026030600040450.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300381","BK0070","BK0239","BK0077"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2616238019","title":"溢多利（300381）披露产品获得欧盟批准注册公告，3月2日股价下跌4.13%","url":"https://stock-news.laohu8.com/highlight/detail?id=2616238019","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2616238019?lang=zh_cn&edition=full","pubTime":"2026-03-02 17:49","pubTimestamp":1772444945,"startTime":"0","endTime":"0","summary":"截至2026年3月2日收盘，溢多利报收于6.74元，较前一交易日下跌4.13%，最新总市值为33.1亿元。近日，广东溢多利生物科技股份有限公司发布公告称，其全资子公司德国Victory Enzymes GmbH获得欧盟委员会批准，其6-植酸酶产品可在欧盟市场作为猪、家禽及部分鸟类饲料添加剂使用，批准文号为 2026/404，有效期至2036年3月17日。该产品获批有助于丰富公司在欧盟市场的产品矩阵，完善全球化布局，提升饲用酶制剂领域的市场竞争力和品牌影响力。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026030200026786.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["FSXEmain","BK0070","BK0077","FESXmain","BK0239","300381"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2616384692","title":"溢多利：截至2026年2月27日，公司股东人数为20415户","url":"https://stock-news.laohu8.com/highlight/detail?id=2616384692","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2616384692?lang=zh_cn&edition=full","pubTime":"2026-03-02 16:45","pubTimestamp":1772441118,"startTime":"0","endTime":"0","summary":"证券之星消息，溢多利(300381)03月02日在投资者关系平台上答复投资者关心的问题。投资者提问：请问截止2月底的股东人数是多少？谢谢溢多利回复：您好，截至2026年2月27日，公司股东人数为20415户，感谢您的关注！以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026030200023194.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0077","BK0239","BK0070","300381"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2616826195","title":"溢多利最新公告：公司产品获得欧盟批准注册","url":"https://stock-news.laohu8.com/highlight/detail?id=2616826195","media":"证券之星","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2616826195?lang=zh_cn&edition=full","pubTime":"2026-03-01 16:30","pubTimestamp":1772353841,"startTime":"0","endTime":"0","summary":"溢多利(300381.SZ)公告称，公司全资子公司德国Victory Enzymes GmbH 于近日获得欧盟委员会签发的批准文件，批准其植酸酶产品作为猪、家禽及部分鸟类饲料添加剂在欧盟市场使用。此次获批不仅丰富了公司在欧盟市场的产品矩阵，完善了公司全球化市场布局版图，还提升了公司在饲用酶制剂领域的市场竞争力和品牌影响力。但需注意，公司相关产品未来销售情况受多种因素影响，对公司业绩的影响具有不确定性。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026030100004437.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["FSXEmain","300381","BK0070","FESXmain","BK0239","BK0077"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2610198936","title":"溢多利：公司立足生物产业，致力于生物技术在营养与健康、食品饮料、护理清洁、纺织皮革、纸浆造纸、生物能源、生态农业、再生资源等领域的绿色、安全、高效应用","url":"https://stock-news.laohu8.com/highlight/detail?id=2610198936","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2610198936?lang=zh_cn&edition=full","pubTime":"2026-02-10 15:04","pubTimestamp":1770707060,"startTime":"0","endTime":"0","summary":"证券之星消息，溢多利02月09日在投资者关系平台上答复投资者关心的问题。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026021000019012.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["159945","BK0077","300381","BK0070","BK0239","000807.SH","159843"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2608947298","title":"股市必读：溢多利(300381)股东户数2.01万户，较上期增加1.11%","url":"https://stock-news.laohu8.com/highlight/detail?id=2608947298","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2608947298?lang=zh_cn&edition=full","pubTime":"2026-02-03 03:05","pubTimestamp":1770059114,"startTime":"0","endTime":"0","summary":"截至2026年2月2日收盘，溢多利报收于6.7元，下跌1.9%，换手率1.44%，成交量7.07万手，成交额4799.38万元。当日关注点来自交易信息汇总：2月2日主力资金净流出7.12万元，游资资金净流入34.04万元。股本股东变化股东户数变动近日溢多利披露，截至2026年1月30日公司股东户数为2.01万户，较12月31日增加220.0户，增幅为1.11%。户均持股数量由上期的2.48万股减少至2.45万股，户均持股市值为16.73万元。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026020300001812.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0077","BK0070","300381","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2606377713","title":"溢多利最新公告：2025年预亏1300万元—2600万元同比由盈转亏","url":"https://stock-news.laohu8.com/highlight/detail?id=2606377713","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2606377713?lang=zh_cn&edition=full","pubTime":"2026-01-28 19:40","pubTimestamp":1769600410,"startTime":"0","endTime":"0","summary":"溢多利(300381.SZ)发布业绩预告，预计2025年净利润亏损1300万元—2600万元，上年同期净利润3109.19万元，同比由盈转亏。报告期内，为维护老客户及推广新产品，销售费用有所增加；理财收益和利息收入减少；子公司计提资产减值损失及母公司产生固定资产报废损失。以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026012800037492.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0077","300381","BK0070","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2605544138","title":"溢多利：公司R-PET酶目前已完成菌株构建及小试中试","url":"https://stock-news.laohu8.com/highlight/detail?id=2605544138","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2605544138?lang=zh_cn&edition=full","pubTime":"2026-01-23 08:54","pubTimestamp":1769129642,"startTime":"0","endTime":"0","summary":"证券之星消息，溢多利01月22日在投资者关系平台上答复投资者关心的问题。项目前景怎么样？会成为公司未来主力产品吗？该产品将主要用于生物法降解废旧塑料和织物，重新回收作为再生料使用，可极大降低塑料污染，有效减少碳足迹，在双碳背景下具有良好的市场前景。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026012300006684.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0077","300381","BK0070","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2603667243","title":"溢多利：洗涤酶产品研发和验证周期相对较长","url":"https://stock-news.laohu8.com/highlight/detail?id=2603667243","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2603667243?lang=zh_cn&edition=full","pubTime":"2026-01-14 15:04","pubTimestamp":1768374256,"startTime":"0","endTime":"0","summary":"公司洗涤酶产品自上市以来，持续与各类日化企业开展合作与应用实验，逐步得到客户认可，实现国产替代。公司一直重视洗涤酶产品的研发和销售，不断加大投入，优化营销队伍建设，丰富产品种类，从剂型到功效再到产品性能，都在逐步提升和完善。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026011400019875.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0070","BK0077","300381","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2601893429","title":"溢多利（300381）披露控股股东部分股份质押展期公告，1月6日股价上涨1.49%","url":"https://stock-news.laohu8.com/highlight/detail?id=2601893429","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2601893429?lang=zh_cn&edition=full","pubTime":"2026-01-06 17:51","pubTimestamp":1767693080,"startTime":"0","endTime":"0","summary":"公司近日发布公告称，广东溢多利生物科技股份有限公司于2026年1月5日接到控股股东珠海市金大地投资有限公司通知，金大地投资将其持有的2,500万股公司股份办理了质押展期，占其所持股份比例17.55%，占公司总股本比例5.09%，质押用途为偿还债务，展期后质押到期日为2026年12月31日，质权人为国信证券股份有限公司。本次变动后，金大地投资累计质押股份数量仍为37,500,000股，占其所持股份比例26.32%，占公司总股本比例7.64%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026010600030648.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","300381","BK0070","BK0077"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2601850424","title":"溢多利：截至2025年12月31日股东人数为19833户","url":"https://stock-news.laohu8.com/highlight/detail?id=2601850424","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2601850424?lang=zh_cn&edition=full","pubTime":"2026-01-06 11:33","pubTimestamp":1767670435,"startTime":"0","endTime":"0","summary":"证券之星消息，溢多利(300381)01月05日在投资者关系平台上答复投资者关心的问题。投资者提问：请问截至12月31日公司股东人数多少？谢谢！溢多利回复：您好，截至2025年12月31日，公司股东人数为19833户，感谢您的关注！以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026010600015705.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","300381","BK0070","BK0077"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2593470465","title":"溢多利：前三季度为加快海外市场拓展，销售费用略有增长","url":"https://stock-news.laohu8.com/highlight/detail?id=2593470465","media":"证券日报 ","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2593470465?lang=zh_cn&edition=full","pubTime":"2025-12-24 21:47","pubTimestamp":1766584020,"startTime":"0","endTime":"0","summary":"证券日报网12月24日讯 ，溢多利在12月23日回答调研者提问时表示，去年公司的研发费用和财务费用有所增长，主要是由于公司升级研发中心，不断加大研发投入和新技术、新产品储备，以及对老产品进行提升优化；财务费用的增长是由于资本支出的增加导致自有资金利息收入下降；另外今年前三季度，为加快海外市场拓展，销售费用略有增长。（文章来源：证券日报）\n\n\n海量资讯、精准解读，尽在新浪财经APP","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/stock/relnews/cn/2025-12-24/doc-inhcxizc9657290.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/relnews/cn/2025-12-24/doc-inhcxizc9657290.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK0077","BK0070","300381","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2593470112","title":"溢多利：公司现有的电镀过氧化氢酶主要用于电子产品生产过程中的清洗环节","url":"https://stock-news.laohu8.com/highlight/detail?id=2593470112","media":"证券日报 ","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2593470112?lang=zh_cn&edition=full","pubTime":"2025-12-24 21:47","pubTimestamp":1766584020,"startTime":"0","endTime":"0","summary":"证券日报网12月24日讯 ，溢多利在12月23日回答调研者提问时表示，公司现有的电镀过氧化氢酶主要用于电子产品生产过程中的清洗环节，帮助去除材料表面附着的过氧化氢，具体应用的产品取决于生产商的制造工艺。该产品自去年开始销售，随着公司对菌种研发及产品性能持续进行改进，今年前三季度的销售额和毛利率较去年有所提升，但总体收入占比仍然较小。（文章来源：证券日报）\n\n\n海量资讯、精准解读，尽在新浪财经APP","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/stock/relnews/cn/2025-12-24/doc-inhcxizc9657146.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/relnews/cn/2025-12-24/doc-inhcxizc9657146.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK0239","300381","BK0077","BK0070"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2593496665","title":"溢多利(300381)12月19日股东户数2.03万户，较上期增加0.05%","url":"https://stock-news.laohu8.com/highlight/detail?id=2593496665","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2593496665?lang=zh_cn&edition=full","pubTime":"2025-12-23 17:49","pubTimestamp":1766483365,"startTime":"0","endTime":"0","summary":"证券之星消息，近日溢多利披露，截至2025年12月19日公司股东户数为2.03万户，较12月10日增加11.0户，增幅为0.05%。在化学制药行业个股中，溢多利股东户数低于行业平均水平，截至12月19日，化学制药行业平均股东户数为3.48万户。从股价来看，2025年12月10日至2025年12月19日，溢多利区间跌幅为3.28%，在此期间股东户数增加11.0户，增幅为0.05%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2025122300028623.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["300381","BK0070","BK0239","BK0077"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"ret":0,"serverTime":1777114977773,"stockEarnings":[{"period":"1week","weight":-0.0064},{"period":"1month","weight":-0.0506},{"period":"3month","weight":-0.1318},{"period":"6month","weight":-0.1042},{"period":"1year","weight":-0.198},{"period":"ytd","weight":-0.0506}],"compareEarnings":[{"period":"1week","weight":0.007},{"period":"1month","weight":0.0377},{"period":"3month","weight":-0.0136},{"period":"6month","weight":0.0328},{"period":"1year","weight":0.2374},{"period":"ytd","weight":0.028}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"广东溢多利生物科技股份有限公司","boardCode":"AI0027","boardName":"医药制造业","stockholders":"20210人(较上一季度减少1.00%)","perCapita":"24212股","listingDate":"2014-01-28","address":"广东省珠海市香洲区南屏高科技工业区屏北一路8号","registeredCapital":"49106万元","survey":" 广东溢多利生物科技股份有限公司的主营业务是生物酶制剂、生物合成品及植物提取物的研发、生产、销售和服务，并向客户提供整体生物技术解决方案。公司的主要产品是生物酶制剂、生物合成品、植物提取物。公司荣获了国家工信部认定的“饲料用酶制剂产品国家制造业单项冠军企业”荣誉称号。","listedPrice":27.88},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.42.0","shortVersion":"4.42.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"溢多利(300381)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供溢多利(300381)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"溢多利,300381,溢多利股票,溢多利股票老虎,溢多利股票老虎国际,溢多利行情,溢多利股票行情,溢多利股价,溢多利股市,溢多利股票价格,溢多利股票交易,溢多利股票购买,溢多利股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"溢多利(300381)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供溢多利(300381)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}